Plain-English translation of NCT06123156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After surgery to remove rectal cancer, many men experience erectile dysfunction—even when nerves are carefully preserved during the operation. This trial is testing whether starting (a medication that improves blood flow to support erections) early after surgery—within 30 days—and continuing it for 10 months can help prevent or reduce this common side effect. Half of the men in the study will receive the medication, and half will receive a placebo (inactive pill) to see if the treatment actually works.
Erectile dysfunction after rectal cancer surgery happens in many men and significantly affects their quality of life. Research suggests that starting this medication early might prevent permanent tissue damage that can develop after surgery, but this approach hasn't been thoroughly tested in men with rectal cancer yet.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would start the treatment (either the medication or placebo) about 30 days after your rectal cancer surgery, once you've healed from the operation. You would take a daily pill for 10 months while attending regular study visits where doctors will monitor your progress and ask questions about your sexual health and overall well-being. You'll be randomly assigned to receive either the active medication or a placebo, and neither you nor your doctor will know which one you're taking until the study ends.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France